Identity
HGNC
LOCATION
7q31.1
LOCUSID
ALIAS
ERdj4,MDG-1,MDG1,MST049,MSTP049
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 4189
MIM: 602634
HGNC: 6968
Ensembl: ENSG00000128590
Variants:
dbSNP: 4189
ClinVar: 4189
TCGA: ENSG00000128590
COSMIC: DNAJB9
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000128590 | ENST00000249356 | Q9UBS3 |
| ENSG00000128590 | ENST00000249356 | Q6FIF1 |
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37561833 | 2023 | Expression of DNAJB9 and some other genes is more sensitive to SWCNTs in normal human astrocytes than glioblastoma cells. | 0 |
| 37561833 | 2023 | Expression of DNAJB9 and some other genes is more sensitive to SWCNTs in normal human astrocytes than glioblastoma cells. | 0 |
| 32557205 | 2021 | Clinicopathological characteristics and outcome of patients with fibrillary glomerulonephritis: DNAJB9 is a valuable histologic marker. | 3 |
| 33966034 | 2021 | DNAJB9 suppresses the metastasis of triple-negative breast cancer by promoting FBXO45-mediated degradation of ZEB1. | 20 |
| 32557205 | 2021 | Clinicopathological characteristics and outcome of patients with fibrillary glomerulonephritis: DNAJB9 is a valuable histologic marker. | 3 |
| 33966034 | 2021 | DNAJB9 suppresses the metastasis of triple-negative breast cancer by promoting FBXO45-mediated degradation of ZEB1. | 20 |
| 31884339 | 2020 | Long non-coding RNA SNHG5 regulates chemotherapy resistance through the miR-32/DNAJB9 axis in acute myeloid leukemia. | 19 |
| 32049014 | 2020 | Hepatic DNAJB9 Drives Anabolic Biasing to Reduce Steatosis and Obesity. | 9 |
| 32622524 | 2020 | DNAJB9-positive monotypic fibrillary glomerulonephritis is not associated with monoclonal gammopathy in the vast majority of patients. | 17 |
| 31884339 | 2020 | Long non-coding RNA SNHG5 regulates chemotherapy resistance through the miR-32/DNAJB9 axis in acute myeloid leukemia. | 19 |
| 32049014 | 2020 | Hepatic DNAJB9 Drives Anabolic Biasing to Reduce Steatosis and Obesity. | 9 |
| 32622524 | 2020 | DNAJB9-positive monotypic fibrillary glomerulonephritis is not associated with monoclonal gammopathy in the vast majority of patients. | 17 |
| 31010480 | 2019 | Serum levels of DNAJB9 are elevated in fibrillary glomerulonephritis patients. | 12 |
| 31227146 | 2019 | New developments in the diagnosis of fibrillary glomerulonephritis. | 20 |
| 31285458 | 2019 | Targeting DNAJB9, a novel ER luminal co-chaperone, to rescue ΔF508-CFTR. | 13 |
Citation
Dessen P
DNAJB9 (DnaJ heat shock protein family (Hsp40) member B9)
Atlas Genet Cytogenet Oncol Haematol. 2007-04-01
Online version: http://atlasgeneticsoncology.org/gene/47161/dnajb9
